Sana Biotechnology is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a team of 200 plus scientists, engineers, clinicians and biotechnology veterans creating an enduring company that makes meaningful medicines and changes how we approach treating disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/23/20 | $700,000,000 | Venture |
Alaska Permanent Fund Altitude Life Science Ventures ARCH Venture Partners Baillie Gifford Canada Pension Plan Investment Board F-Prime Capital Partners Flagship Pioneering GV Omega Funds Public Sector Pension Investment Board | undisclosed |
